First communication on the efficacy of combined Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, Clarisse Dromain, Mounir Trimech, Ana Dolcan, Solange Peters, John Prior, Niklaus Schaefer
26 October 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, Tim R Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Michael Hundemer, Niels Weinhold, Karsten Rippe, Stefan Fröhling, Stefan B Eichmüller, Lukas BunseSee the full list of authors
17 October 2022
Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case reportMaxwell J Kroloff, Josefin-Beate Holz, Omer Stern, Christopher J Shepherd, Michelle Morrow, Louis Kayitalire, Deborah J Wong
6 October 2022
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case reportDan Li, Yimei Que, Shengnan Ding, Guang Hu, Wen Wang, Xia Mao, Ying Wang, Chunrui Li, Liang Huang, Jianfeng Zhou, Wei Zhang, Min Xiao
22 September 2022
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccineDjordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, Nancy M Hardy, Destiny Omili, Thierry Iraguha, Peter D Burbelo, Etse Gebru, Xiaoxuan Fan, John Baddley, Tim Luetkens, Saurabh Dahiya, Aaron P Rapoport
17 July 2022
Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remissionTejus Satish, Shaheer Khan, Matt Levin, Richard Carvajal, Angela J Yoon
29 October 2021
Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case reportPaul Sackstein, Jacob Zaemes, Chul Kim
30 July 2021
Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case reportRebecca Baur, Regina Jitschin, Soraya Kharboutli, Andrej Stoll, Simon Völkl, Maike Büttner-Herold, Daniela Schmidt, Wolf Rösler, Andreas Mackensen, Dimitrios Mougiakakos
16 July 2021
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumabSang T. Kim, Jean Tayar, Siqing Fu, Danxia Ke, Elliot Norry, Amy Sun, Juli Miller, David S. Hong
7 July 2021
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevanceTricia Cottrell, Jiajia Zhang, Boyang Zhang, Genevieve J Kaunitz, Poromendro Burman, Hok-Yee Chan, Franco Verde, Jody E Hooper, Hans Hammers, Mohamad E Allaf, Hongkai Ji, Janis Taube, Kellie N Smith
6 July 2021